Pharmaceutical Industry

Is Our Failure to Invest in an Ebola Cure 'Morally Bankrupt' or Financially Prudent?

Natalie Nezhati | Posted 19.08.2014 | UK
Natalie Nezhati

It could be said that the investment of resources into a cure that could carry a price-tag of £1m plus per person to turn a profit is, in purely financial terms, a ridiculous thing to do. With many pharmaceutical companies linking their moral accountability solely with their shareholders, for those who contract unprofitable, neglected diseases it's often a case of "bad luck" and in many cases "goodbye".

The Not-So-Secret Antibody Treating Americans For 'Incurable' Ebola

The Huffington Post UK | Jessica Elgot | Posted 07.08.2014 | UK

If there's no treatment or cure for Ebola, why have two American patients been treated with a not-so-secret antibody that seems, so far, to be aiding ...

Irish Psychiatry and Consent

Aaron Vallely | Posted 06.08.2014 | UK
Aaron Vallely

"I believe", Mary told me at her house in Cork, "the biggest issue around this is human rights. The human right to decide what you want to do for yourself. " Regarding Electroshock in Ireland, Mary told me that the capacity to consent is not there because there are two words planted around it, 'unable' and 'unwilling'.

Jessica Elgot

We May Have Already Discovered The Cure For Ebola - So Why Are People Still Dying?

HuffingtonPost.com | Jessica Elgot | Posted 31.07.2014 | UK

The cure for Ebola may have already have been developed by drugs companies, but ethical dilemmas and financial concerns are holding back hopes of a fa...

Pfizer's Bid To Gobble Up UK Rival AstraZeneca May Not Be Over

The Huffington Post UK/PA | Posted 21.05.2014 | UK

Hopes for Pfizer's apparently doomed attempt to take over AstraZeneca flickered back to life today on a report that one of the largest shareholders in...

Skeletons in the Cupboard: Open the Door on Hidden Clinical Trials

Michelle Beckett | Posted 18.07.2014 | UK
Michelle Beckett

Last year I put my house on the market. Mostly, I'm too busy to notice the clutter and untidiness that accompanies the life of a lone mum working full time, but I guessed the prospective viewers might...

AstraZeneca Rejects Pfizer's Final Deal

The Huffington Post UK | Posted 19.05.2014 | UK

AstraZeneca today rejected a final £69 billion takeover offer from Pfizer, saying the American company had still significantly undervalued the Britis...

UK plc Should Not Be the Victim of Big Pharma's Innovation Crisis

Ann McKechin | Posted 14.07.2014 | UK Politics
Ann McKechin

UK plc should not pay for Pfizer's crisis of innovation. AstraZeneca is a strategically important company to the UK, developing vital drugs both here and around the world. A takeover driven by tax efficiency and cash dividend rather than research and innovation imperils the future of UK science, research jobs, and exports.

Osborne Will Get 'Hard-Nosed' With Pfizer

The Huffington Post UK/PA | Posted 10.05.2014 | UK Politics

The boss of US drug giant Pfizer has said the firm's proposed takeover of British-based AstraZeneca is a "win-win for society". Pfizer chairman and...

When a Doctor Eats an Apple Does He Have an Existential Moment?

Rob Blakeman | Posted 23.06.2014 | UK Lifestyle
Rob Blakeman

It's down to you to take care of the health of you and yours and avoid using dangerous medications at all costs. Small changes in our everyday lives can result in big inspiration. Don't forget we are organic creatures so it makes perfect sense that organic products are best for us-not manmade pharmaceuticals.

Energy Firm Cyber-defence Too Weak

Graham Welch | Posted 03.05.2014 | UK Tech
Graham Welch

Why are these critical infrastructure companies failing these tests? After all most of these large organizations are serious about cybersecurity. They run specialized departments tasked with protecting two key networks: data center (servers) and office automation (workstations).

The Truth About Health - a Bitter Pill to Swallow

David Green | Posted 09.02.2014 | UK Lifestyle
David Green

GK Chesterton, the great author who inspired Gandhi to end British colonial rule in India, observed: "I owe my success to having listened respectfull...

Wearing the White Cashmere Coat

Sarah Phillips | Posted 25.01.2014 | UK
Sarah Phillips

I left Dublin this year, at the close of ISPOR's 16th Annual European Congress, thinking in terms of what is important when making a decision. The parameters need to be simple, intuitive and transparent in any evaluation model. This sounds straightforward, but which parameters should be measured, and how is a fair decision made?

Why Drug Companies are Turning to Fish Oil

Aidan Goggins | Posted 23.01.2014 | UK Lifestyle
Aidan Goggins

It was nice to see that on the topic of omega 3 fish oil consumption, of which I have been a staunch defender, I have received unlikely support from Big Pharma. They have been casting their nets for the next big heart cure, and fish oil is the catch of the day.

The Problem of Antibiotic Resistance Could Provide a Stimulus for Economic Recovery

Stephen Caddick | Posted 18.05.2013 | UK Universities & Education
Stephen Caddick

If we take the right approach to this major challenge, we could improve our economy along with the health of our nation we have all of the pieces we need at our disposal, but we need concerted action to get them to work together.

Superbugs 'Could Take Us Back To 19th Century'

The Huffington Post UK | Posted 11.03.2013 | UK

The "catastrophic" threat posed by antibiotic resistance should be ranked alongside terrorism on a list of threats to the nation, the Government's Chi...

Working Together to Tackle Neglected Tropical Diseases

Simon Bush | Posted 15.01.2013 | UK
Simon Bush

The goal? To tackle a group of 17 infectious diseases that between them, affect over 1.4 billion of the poorest and most vulnerable people in the world.

He's Earning HOW Much?

Charlie Thomas | Posted 29.10.2012 | UK

Biopharmaceutical giant AstraZeneca has revealed its new chief executive Pascal Soriot will receive a base salary of £1.1 million a year after jumpin...

The Future for Market Research

Sarah Phillips | Posted 01.12.2012 | UK
Sarah Phillips

The commercial backdrop for any pharmaceutical company bringing a product to market is the changing market landscape they face. This is largely one of fragmentation, both in terms of the types of patient who are appropriate for targeting and in terms of the disease.

WATCH: Water Levitated With Sound Waves To Create Better Drugs

Huffington Post UK | Michael Rundle | Posted 17.11.2012 | UK Tech

Scientists have turned to levitation to improve the development of new drugs. The technique involves using sound waves to make water droplets hover...

Is a Tarnished Reputation a Bitter Pill to Swallow for Giant Pharmaceutical Companies?

Ehud Furman | Posted 11.11.2012 | UK Tech
Ehud Furman

If distrust of the pharmaceutical industry is not high enough, then fact sheets issued by the World Health Organisation warning of massive corruption throughout the pharmaceutical supply chain is certainly not going to inspire much confidence.

Lifting the Burden of HIV/AIDS

Davinder Kumar | Posted 10.11.2012 | UK
Davinder Kumar

At 13, the only dream Ganesh has, is to live. His parents and brother - all died of AIDS. Of the family of four, he is now the only survivor and HIV positive. Ganesh got HIV from his mother and is among more than 100,000 children below the age of 15 who are living with HIV/AIDS in India.

Filmeopathy: The New Miracle Cure

Will Porter | Posted 22.10.2012 | Home
Will Porter

What's your favourite home remedy? I know some people swear by chicken soup, others a hot water bottle, when I'm ill I prefer copious amounts of tea and a DVD.

A Profession by Any Other Name - The Shame of Market Research

Sarah Phillips | Posted 01.10.2012 | UK
Sarah Phillips

I was carving a loaf of bread this weekend, with my new bread knife. For some reason, I didn't look at the knife and think to myself, 'Wow, that's some knife skills you have, maybe you could be a surgeon'.

NHS Patients Facing Medicine Shortage

PA/The Huffington Post UK | Posted 15.05.2012 | UK

Patients are suffering because of a shortage of some NHS prescription medicines, a Parliamentary group has warned. Shortages of some medicines are ...